Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Saved in:
| Title: | Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. |
|---|---|
| Authors: | Juan-Giner A; Epicentre, Paris, France., Kimathi D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Grantz KH; Department of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Hamaluba M; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Kazooba P; Epicentre Mbarara Research Centre, Mbarara, Uganda., Njuguna P; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Fall G; Institut Pasteur Dakar, Dakar, Senegal., Dia M; Institut Pasteur Dakar, Dakar, Senegal., Bob NS; Institut Pasteur Dakar, Dakar, Senegal., Monath TP; Crozet BioPharma LLC, Devens, MA, USA., Barrett AD; Sealy Institute for Vaccines Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Hombach J; Immunization, Vaccines & Biologicals, WHO, Geneva, Switzerland., Mulogo EM; Department of Community Health, Mbarara University of Science & Technology, Mbarara, Uganda., Ampeire I; Expanded Program on Immunization, Ministry of Health, Kampala, Uganda., Karanja HK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Nyehangane D; Epicentre Mbarara Research Centre, Mbarara, Uganda., Mwanga-Amumpaire J; Epicentre Mbarara Research Centre, Mbarara, Uganda., Cummings DAT; Department of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA., Bejon P; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Warimwe GM; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Grais RF; Epicentre, Paris, France. Electronic address: rebecca.grais@epicentre.msf.org. |
| Source: | Lancet (London, England) [Lancet] 2021 Jan 09; Vol. 397 (10269), pp. 119-127. |
| Publication Type: | Equivalence Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33422245 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Juan-Giner+A%22">Juan-Giner A</searchLink>; Epicentre, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kimathi+D%22">Kimathi D</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Grantz+KH%22">Grantz KH</searchLink>; Department of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Hamaluba+M%22">Hamaluba M</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kazooba+P%22">Kazooba P</searchLink>; Epicentre Mbarara Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Njuguna+P%22">Njuguna P</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Fall+G%22">Fall G</searchLink>; Institut Pasteur Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Dia+M%22">Dia M</searchLink>; Institut Pasteur Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Bob+NS%22">Bob NS</searchLink>; Institut Pasteur Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Monath+TP%22">Monath TP</searchLink>; Crozet BioPharma LLC, Devens, MA, USA.<br /><searchLink fieldCode="AU" term="%22Barrett+AD%22">Barrett AD</searchLink>; Sealy Institute for Vaccines Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hombach+J%22">Hombach J</searchLink>; Immunization, Vaccines & Biologicals, WHO, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mulogo+EM%22">Mulogo EM</searchLink>; Department of Community Health, Mbarara University of Science & Technology, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Ampeire+I%22">Ampeire I</searchLink>; Expanded Program on Immunization, Ministry of Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Karanja+HK%22">Karanja HK</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nyehangane+D%22">Nyehangane D</searchLink>; Epicentre Mbarara Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Mwanga-Amumpaire+J%22">Mwanga-Amumpaire J</searchLink>; Epicentre Mbarara Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Cummings+DAT%22">Cummings DAT</searchLink>; Department of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Bejon+P%22">Bejon P</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Warimwe+GM%22">Warimwe GM</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Grais+RF%22">Grais RF</searchLink>; Epicentre, Paris, France. Electronic address: rebecca.grais@epicentre.msf.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2021 Jan 09; Vol. 397 (10269), pp. 119-127. – Name: TypePub Label: Publication Type Group: TypPub Data: Equivalence Trial; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33422245 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(20)32520-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 119 Titles: – TitleFull: Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Juan-Giner A – PersonEntity: Name: NameFull: Kimathi D – PersonEntity: Name: NameFull: Grantz KH – PersonEntity: Name: NameFull: Hamaluba M – PersonEntity: Name: NameFull: Kazooba P – PersonEntity: Name: NameFull: Njuguna P – PersonEntity: Name: NameFull: Fall G – PersonEntity: Name: NameFull: Dia M – PersonEntity: Name: NameFull: Bob NS – PersonEntity: Name: NameFull: Monath TP – PersonEntity: Name: NameFull: Barrett AD – PersonEntity: Name: NameFull: Hombach J – PersonEntity: Name: NameFull: Mulogo EM – PersonEntity: Name: NameFull: Ampeire I – PersonEntity: Name: NameFull: Karanja HK – PersonEntity: Name: NameFull: Nyehangane D – PersonEntity: Name: NameFull: Mwanga-Amumpaire J – PersonEntity: Name: NameFull: Cummings DAT – PersonEntity: Name: NameFull: Bejon P – PersonEntity: Name: NameFull: Warimwe GM – PersonEntity: Name: NameFull: Grais RF IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 01 Text: 2021 Jan 09 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 397 – Type: issue Value: 10269 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |